Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,3,0.99 [0.84-1.17],0.909597487977817
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,3,0.95 [0.83-1.10],0.516534729589299
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,3,0.97 [0.84-1.11],0.625841742407494
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,3,0.43 [0.08-2.29],0.323795805156716
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,3,0.92 [0.72-1.18],0.522462672412277
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,3,1.13 [0.68-1.86],0.636042708277138
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,3,0.93 [0.35-2.50],0.893392524981629
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,3,0.90 [0.40-1.99],0.791119773181813
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,3,0.95 [0.64-1.40],0.797400282582137
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,3,0.94 [0.63-1.41],0.774225766052265
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,Inverse variance weighted,3,6.24 [1.14-34.02],0.034484747968576
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,3,0.46 [0.13-1.57],0.215911105043675
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,3,0.91 [0.51-1.64],0.75890124279377
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,3,1.00 [0.80-1.25],0.994710933575168
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,3,0.93 [0.70-1.23],0.611912576198376
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,3,1.30 [0.54-3.13],0.551754766725011
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,3,0.52 [0.26-1.06],0.0732305550737355
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,3,1.11 [0.78-1.57],0.57183677771279
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,3,0.99 [0.62-1.60],0.98158106054253
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,3,0.96 [0.73-1.27],0.778860081476475
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,3,0.97 [0.76-1.24],0.788190554413947
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,3,1.33 [0.48-3.65],0.580917800047632
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,3,0.63 [0.37-1.07],0.0872342176992798
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,Inverse variance weighted,3,1.07 [0.80-1.44],0.650168389462168
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,3,1.03 [0.81-1.29],0.826096743037613
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,3,1.11 [0.97-1.27],0.142322736028476
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,3,0.98 [0.88-1.08],0.656958946508509
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,3,1.05 [0.82-1.36],0.687453699982516
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,3,0.87 [0.60-1.26],0.462400816379601
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,Inverse variance weighted,3,1.49 [0.71-3.16],0.295168345262987
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,3,1.21 [0.83-1.76],0.324064090527366
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,3,0.94 [0.63-1.40],0.75893709280829
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,3,1.02 [0.82-1.27],0.872246089775768
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,3,0.95 [0.75-1.21],0.677920569030433
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,3,1.00 [0.84-1.18],0.957743003406027
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,3,0.84 [0.70-1.00],0.0523524320973967
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,3,0.91 [0.79-1.06],0.214008065969169
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,3,0.93 [0.79-1.09],0.350198259022062
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,3,1.02 [0.84-1.24],0.843753027061407
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,3,0.94 [0.76-1.17],0.589125068640015
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,3,0.95 [0.77-1.16],0.607493116184811
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,3,1.15 [0.49-2.68],0.753693738009289
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,3,0.83 [0.35-1.93],0.661360136073592
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,3,0.96 [0.64-1.43],0.840986269855741
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,3,0.95 [0.84-1.08],0.419563526212261
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,3,1.02 [0.79-1.32],0.858131046154982
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,3,0.80 [0.59-1.10],0.169149138505833
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,3,0.86 [0.68-1.07],0.177355127700193
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,3,0.95 [0.70-1.29],0.740465100446558
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,3,1.12 [0.67-1.88],0.663745479458722
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,Inverse variance weighted,3,2.01 [1.15-3.54],0.0150740318787128
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",Inverse variance weighted,3,1.31 [0.68-2.55],0.420656932909265
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",Inverse variance weighted,3,0.57 [0.10-3.18],0.524081439321426
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,3,1.12 [0.53-2.36],0.77547599630681
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,3,0.78 [0.52-1.15],0.208477107450185
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,3,0.90 [0.76-1.06],0.21376485278038
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,3,0.89 [0.70-1.14],0.353359617336903
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,3,0.87 [0.47-1.64],0.673242292845468
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,3,0.66 [0.25-1.73],0.400683561638011
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,3,0.97 [0.81-1.16],0.716192564786294
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,3,0.90 [0.56-1.43],0.645619256802028
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,3,1.06 [0.94-1.21],0.325410545621105
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,3,1.21 [0.64-2.29],0.551840755453705
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,3,1.03 [0.75-1.41],0.877417361853404
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,3,1.38 [0.63-3.01],0.42100139561029
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,3,0.66 [0.37-1.15],0.140771532724812
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,Inverse variance weighted,3,1.10 [0.93-1.31],0.266699245246846
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,3,1.02 [0.79-1.33],0.853094240266641
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,3,1.14 [0.79-1.66],0.484770185409752
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,3,1.11 [0.82-1.51],0.505486766214486
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,3,1.00 [0.85-1.18],0.988211743639444
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,3,1.00 [0.75-1.33],0.991839824179887
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,3,0.73 [0.46-1.16],0.18383305724856
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,3,0.86 [0.64-1.14],0.296474873735929
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,3,0.85 [0.73-0.99],0.0317299709021207
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,3,0.71 [0.34-1.47],0.360574335568893
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,3,0.81 [0.52-1.25],0.341370441816694
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,3,1.05 [0.74-1.49],0.778409837361906
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,3,1.59 [0.89-2.83],0.120336916585657
